Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 3
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 4, 2008
Concurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug
Alberto E Paniz-Mondolfi, Alexandra M Pérez-Álvarez, Oscar Reyes-Jaimes, Gustavo Socorro, Olga Zerpa, et al
Therapeutics and Clinical Risk Management 2008, 4:659-663
Published Date: 6 June 2008
The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
Alex C Spyropoulos, Sharyl Magnuson, Sei Keng Koh
Therapeutics and Clinical Risk Management 2008, 4:653-657
Published Date: 6 June 2008
An “acquired” hemoglobin J variant in a sickle cell disease patient
Nawwar Swedan, Kathleen Nicol, Phylis Moder, Samir Kahwash
Therapeutics and Clinical Risk Management 2008, 4:649-652
Published Date: 6 June 2008
Valproate-associated reversible encephalopathy in a 3-year-old girl with Pallister-Killian syndrome
Thorsten Gerstner, Nellie Bell, Stephan A Koenig
Therapeutics and Clinical Risk Management 2008, 4:645-647
Published Date: 6 June 2008
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
Hideki Ishida, Kazunari Tanabe
Therapeutics and Clinical Risk Management 2008, 4:641-644
Published Date: 6 June 2008
Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time
Tam Ly, Jyoti Gulia, Vasilios Pyrgos, Masashi Waga, Shmuel Shoham
Therapeutics and Clinical Risk Management 2008, 4:637-640
Published Date: 6 June 2008
Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy
Harry Tagbor, Jane Bruce, Edmund Browne, Brian Greenwood, Daniel Chandramohan
Therapeutics and Clinical Risk Management 2008, 4:631-636
Published Date: 6 June 2008
Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment
Sigliti-Henrietta Pelidou, Sotirios Giannopoulos, Sotiria Tzavidi, Georgios Lagos, Athanassios P Kyritsis
Therapeutics and Clinical Risk Management 2008, 4:627-630
Published Date: 6 June 2008
Treatment strategies in mucous membrane pemphigoid
Ann G Neff, Matthew Turner, Diya F Mutasim
Therapeutics and Clinical Risk Management 2008, 4:617-626
Published Date: 6 June 2008
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders
Takekazu Kubo, Atsushi Yamaguchi, Nobuyoshi Iwata, Toshihide Yamashita
Therapeutics and Clinical Risk Management 2008, 4:605-615
Published Date: 6 June 2008
Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, et al
Therapeutics and Clinical Risk Management 2008, 4:599-603
Published Date: 6 June 2008
AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker
Therapeutics and Clinical Risk Management 2008, 4:587-597
Published Date: 6 June 2008
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
Enriqueta Felip, Rafael Rosell
Therapeutics and Clinical Risk Management 2008, 4:579-585
Published Date: 6 June 2008
Atripla™ – HIV therapy in one pill
Boris Julg, Johannes R Bogner
Therapeutics and Clinical Risk Management 2008, 4:573-577
Published Date: 6 June 2008
Editorial ||FREE PAPER||
Garry M Walsh
Therapeutics and Clinical Risk Management 2008, 4:0-0
Published Date: 6 June 2008